Navigation Links
Acorda Therapeutics to Host Analyst and Investor Reception

ual results to differ materially, including Acorda Therapeutics' ability to successfully market and sell Zanaflex Capsules, the risk of unfavorable results from future studies of Fampridine-SR, delays in obtaining or failure to obtain FDA approval of Fampridine-SR, competition, the ability to obtain additional financing to support Acorda Therapeutics' operations, unfavorable results from its preclinical programs, and failure to protect its intellectual property or to defend against the intellectual property claims of others. These and other risks are described in greater detail in Acorda Therapeutics' filings with the Securities and Exchange Commission. Acorda Therapeutics may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Acorda Therapeutics disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About Acorda Therapeutics

Acorda Therapeutics is a biotechnology company developing therapies for SCI, MS and related nervous system disorders. The Company's marketed products include Zanaflex Capsules(TM) (tizanidine hydrochloride), a short-acting drug for the management of spasticity. For full prescribing information, please go to www.zanaflexcapsules.com. Acorda's lead clinical stage product, Fampridine-SR, recently completed a Phase 3 study in people with MS. The Company's pipeline includes a number of products in development for the treatment, regeneration and repair of the spinal cord and brain.

Contact

Acorda Therapeutics
Erica Wishner, 914-347-4300 ext. 162
ewishner@acorda.com


'"/>




Page: 1 2

Related medicine technology :

1. Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting
2. Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
3. Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data Selected for Scientific Highlights Program at the American Academy of Neurology Meeting
4. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
5. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
6. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
7. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
8. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
9. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
10. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
11. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Acorda Therapeutics Host Analyst and Investor Reception
(Date:5/26/2015)...  Over the past several years, numerous studies have ... sleeve gastrectomy, and weight loss surgery in general ... a study conducted by Italian researchers and published in ... obese patients suffering from an overactive bladder tend to ... weight with a laparoscopic sleeve gastrectomy. This is the ...
(Date:5/26/2015)...  PAREXEL International Corporation (NASDAQ: PRXL ) announced ... Sachs Healthcare Conference in Palos Verdes, CA.  Josef ... be making a presentation on PAREXEL and discussing business ... 2015. A live webcast of the presentation ... website at www.PAREXEL.com in the Upcoming Events ...
(Date:5/26/2015)... , May 26, 2015 ... commercial potential ,What,s the future of technologies for ... predictions from 2015. Stay ahead there for data, ... explore sales results, R&D, opportunities and revenue forecasts. ... shows you what,s possible for cell-based ...
Breaking Medicine Technology:Add Overactive Bladder Syndrome to the List of Conditions Shown to Be Improved by a Sleeve Gastrectomy 2PAREXEL International To Present At Goldman Sachs Healthcare Conference 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 2Cell-Based Assays: World Industry and Market Prospects 2015-2025 3Cell-Based Assays: World Industry and Market Prospects 2015-2025 4Cell-Based Assays: World Industry and Market Prospects 2015-2025 5Cell-Based Assays: World Industry and Market Prospects 2015-2025 6Cell-Based Assays: World Industry and Market Prospects 2015-2025 7
... , ALEXANDRIA, Va., July 9 The world-wide explosion of ... of obesity is widely recognized. Could it really be an ... over the increasing prevalence of overweight conditions in our society, ... as a potential direct contributor to obesity. , ...
... BALTIMORE, July 9 Approximately ninety-one percent of dentists say ... to a nationwide member survey conducted by the Academy of ... is caused by a decrease in salivary function. It ... percent of people at risk for tooth decay. During the ...
Cached Medicine Technology:Is Obesity an Oral Bacterial Disease? 2Dry Mouth Linked to Prescription and Over the Counter Drugs 2Dry Mouth Linked to Prescription and Over the Counter Drugs 3
(Date:5/26/2015)... (PRWEB) May 26, 2015 The American ... at America’s 55 poison centers applaud the efforts of ... opioid addiction, according to Stephen T. Kaminski, JD, AAPCC ... of Controlled Substances Act, introduced by Senator Edward J. ... prescribers of opioid pain medications and other controlled substances ...
(Date:5/26/2015)... Sexual harassment and sexual assault are major problems on ... creating opportunities in women's athletics, it is now being used ... In a recent episode of SCI TV , attorney ... Title IX means for university administrators dealing with sexual assault ... to protect students. , In the last 15 years Title ...
(Date:5/26/2015)... IL (PRWEB) May 26, 2015 ... for the summer season, and thanks to the ... wellness solutions, more of their musicians are protecting ... , With over 400 participating groups, Etymotic’s Adopt-a-Band ... Earplugs by Etymotic are now for sale in ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Irwin Gross, ... and directed a hospital-wide Patient Blood Management (PBM) initiative ... reduced overall blood usage by more than 60 percent ... , Covered in detail in an article in the ... in substantially reduced perioperative red cell loss, less acute ...
(Date:5/26/2015)... 2015 Octo Consulting Group (Octo), an ... solutions to the federal marketplace, has named Gaurav “GP” ... In this newly created role, Pal will be responsible ... cloud computing, big data, and digital services. , “We’re ... as we continue to bring clients new and innovative ...
Breaking Medicine News(10 mins):Health News:American Association of Poison Control Centers Supports Legislative Initiatives Targeting the Responsible Prescription of Opioid Pain Medication 2Health News:American Association of Poison Control Centers Supports Legislative Initiatives Targeting the Responsible Prescription of Opioid Pain Medication 3Health News:Paul Greene Explores Title IX and College Sports on SCI TV 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 3Health News:Marching Musicians Getting In Step With Hearing Protection 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 2Health News:Published Study: Patient Blood Management (PBM) Program Slashes Blood Use, Transfusions and Costs while Resulting in Better Patient Outcomes 3Health News:Octo Consulting Group (Octo) Appoints Gaurav “GP” Pal as Vice President of Technology Strategy and Cloud Solutions 2
... cream and a potent neurotoxin, used by Hollywood stars ... form a bacteria, Clostridium botulinum, that causes food poisoning.//, ... form of neurotoxin is playing an important role in ... exploring basic nerve cell function, minute changes that underlie ...
... its therapeutic effect on burned or irritated skin. Looks like there ... be taken as a healthful additive to fruits and // vegetables ... developed by researchers that can be used as an edible coating ... does not appear to affect food taste or appearance and shows ...
... may be increasing the drug resistance across the world., ... in the journal The Lancet, worldwide resistance to drugs ... 12% since the mid-nineties., ,Adamantanes have been used ... 30 years. Previous surveillance studies have identified a low ...
... telecom companies, said Wednesday it had tied up with ... in over 100 cities. // , ,Under the ... of 240 WebWorld cyber stores in 105 cities to ... offer access to the Apollo Telemedicine Networking Foundation (ATNF), ...
... Technology Sleep Laboratory had reported that children who are ... more sleep than others instead of drugs // to ... an issue of over alertness and nervousness, with affected ... of stimulant medications (such as Ritalin) has been shown ...
... for branded Zidovudine in US has lead to approval of ... less and can be imported from other countries. ... treatment of AIDS, the drug prevents the replication of the ... virus. The drug is also used in combination with other ...
Cached Medicine News:Health News:Aloe Vera Coating For Fruits And Vegetables Preservation 2Health News:Children With ADHD May Just Be Sleepy 2
... Ergonomic Design for Unparalleled Comfort Pick one ... the balance. Notice the trigger and ejector positionsright ... because our pipettors are ergonomically designed to help ... of pipetting. Productivity In The Palm Of ...
... Unparalleled Comfort Pick one of our pipettors ... the trigger and ejector positionsright where they should ... are ergonomically designed to help avoid repetitive stress ... Productivity In The Palm Of Your Hand ...
... Pick one of our pipettors up and ... and ejector positionsright where they should beeven if ... designed to help avoid repetitive stress injuries caused ... The Palm Of Your Hand Start dispensing ...
... The total ergonomic solution and best value ... feather touch action and ultra lightweight design ... tip ejection with long, lever tip ejector ... , Accepts universal tips or for greater ...
Medicine Products: